Silk Road Medical to Present at Upcoming Investor Conferences
SUNNYVALE, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that management will present at the following investor conferences.
- Stifel 2022 Healthcare Conference
Presentation on Tuesday, November 15 at 10:20 a.m. Eastern Time
- 4th Annual Wolfe Research Healthcare Conference
Presentation on Wednesday, November 16 at 1:20 p.m. Eastern Time
- 34th Annual Piper Sandler Healthcare Conference
Presentation on Wednesday, November 30 at 3:00 p.m. Eastern Time
Interested parties may access a live and archived webcast of each presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/.
About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.
Lynn Lewis or Marissa Bych
Silk Road Medical